Brain cancer drug trial halted early
NCT ID NCT01068782
Summary
This study tested whether the drug cabozantinib could help control aggressive brain tumors that had returned after initial treatment. It involved 19 people with recurrent grade IV astrocytic tumors and tested four different dosing schedules to find the best balance of effectiveness and safety. The trial was terminated early by the sponsor for business reasons before any results on tumor response could be collected.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTROCYTIC TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Study site
Birmingham, Alabama, 35294, United States
-
Study site
Encinitas, California, 92024, United States
-
Study site
Pleasant Hill, California, 94523, United States
-
Study site
Chicago, Illinois, 60611, United States
-
Study site
Chicago, Illinois, 60637, United States
-
Study site
Boston, Massachusetts, 02115, United States
-
Study site
Detroit, Michigan, 48202, United States
-
Study site
Minneapolis, Minnesota, 55407, United States
-
Study site
Amherst, New York, 14226, United States
-
Study site
Rochester, New York, 14642, United States
-
Study site
Cleveland, Ohio, 44195, United States
-
Study site
Hershey, Pennsylvania, 17033, United States
-
Study site
Dallas, Texas, 75246, United States
-
Study site
Dallas, Texas, 75426, United States
-
Study site
San Antonio, Texas, 78229, United States
-
Study site
Charlottesville, Virginia, 22908, United States
-
Study site
Seattle, Washington, 98122, United States
-
Study site
Calgary, Alberta, Canada
-
Study site
Montreal, Quebec, Canada
Conditions
Explore the condition pages connected to this study.